ClinicalTrials.gg
CompletedNCT06978309Updated Jan 26, 2026

EMG Response in Forearm and Neck Muscles When Comparing Surgical Techniques.

An observational study in Surgical Fatigue, sponsored by Lancaster University. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-26.

Sponsored by Lancaster University · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
9
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 65 studies in Fatigue with a site in United Kingdom — 13 open to participants now, 16 under way, 2 of them phase 3. Fatigue · United Kingdom.

Enrollment
18th of 18
9 · median 62
Started
2025
with 4 others
Observational
18 of 65
2 open now
Registered
53rd of 65
by date
Lead sponsor
5 of 65
Lancaster University

Among the 65 studies in Fatigue with a site in United Kingdom, this one is the 18th largest by enrollment of the 18 observational ones that give a count, is one of 5 that started in 2025, is one of 18 observational ones, and was the 53rd registered.

Fatigue

2,234 studies on the registry are indexed under Fatigue; 430 are open to participants now.

Browse Fatigue studies →

Open to participants now

13 of the 65 studies in Fatigue with a site in United Kingdom are open now. Recruiting first, the newest first:

8 more — sign in →

All 13 open studies →

A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →

Who these studies take

Of the 242 Fatigue studies recruiting now, 113 (47%) set no upper age limit and 99 (41%) stop at 75 or younger; 23 take children under 18; 74 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 65 studies in Fatigue with a site in United Kingdom, or all of them as a file.
02

Study summary

Surgeons are performing an increasing number of minimal access procedures because these offer certain advantages including improved recovery times. However, this also results in surgeons operating for longer periods which inevitably increases the already known prevalence of work-related Musculoskeletal (MSK) injuries amongst surgeons. Work-related MSK disorders account for 26 - 47.5% of illnesses and injuries due to overexertion and repetitive use, in professionals with ergonomically challenging jobs. Robotic-assisted laparoscopic surgery (RALS) is a modern technology that could help mitigate these MSK problems and thereby improve patient care. In comparison to standard laparoscopic surgery (LS), RALS offers steadier wrist movements with a reduced fulcrum effect, thus benefiting the patient.

No study has compared the demands of RALS vs. LS on musculoskeletal fatigue (and subsequent injury risk). The investigators need to determine whether a career using RALS is associated with better musculoskeletal health of surgeons than standard LS when performing complex minimally invasive procedures.

The study will recruit Surgeons who perform prostate and bowel surgical procedures who have experience using RALS and/or LS. Surgeons will complete a series of validated questionnaires before and after each surgery to subjectively determine musculoskeletal strain/pain and will have body composition quantified.

They will be fitted with EMG (to measure muscle fatigue) whilst performing real-life surgery. Analysis of data gathered will be used to show what the short- and long- term musculoskeletal demands are and in turn determine if these are associated with changes in motor control.

The researcher's postulated hypothesis is that RALS should have less musculoskeletal effects both short and long term on surgeons, therefore, highlighting the fact that the implementation of RALS should be less controversial, because in the long run, the most expensive objects in the operating room are the personnel.

03

Conditions studied

  • Surgical Fatigue

Browse trials for

Keywords

  • fatigue
  • Laparoscopic
  • Surgeon wellbeing
  • Robotic surgery
  • EMG
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Healthy, adult laparoscopic and robot- assisted laparoscopic surgeons.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Either a laparoscopic or robot-assisted laparoscopic surgeon.
  • Good musculoskeletal health.
  • Adult.

Exclusion criteria

Exclusion Criteria:

  • Procedures with major complications (above 50% more time than the average for that surgery).
  • Significant co- morbidities that could affect the results of the study. Significant symptoms of musculoskeletal disorder.
  • Anything the investigator feels will affect the study's measurements of safety.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
9 participants (actual)
Target follow-up
2 Weeks
Patient registry
Yes

Groups and cohorts

  • Robot-Assisted Laparoscopic Surgery

    Surgeons performing robot assisted laparoscopic surgery.

    Other: No Interventions

  • Laparoscopic Surgery

    Surgeons performing manual laparoscopic surgery.

    Other: No Interventions

Interventions

  • OtherNo Interventions

    Observational study.

06

What researchers measure

Primary outcomes

  1. Acute muscle activation- percentage of forearm maximal voluntary contraction (%) assessed using EMG frequency.

    This outcome measures the immediate impact of RALS and LS on the surgeon's forearm muscles during a single surgical procedure. It will be quantified by assessing the change in electromyography (EMG) frequency and amplitude recorded during clinically important surgical tasks within the surgeons' first surgery of the day. The contributing measures to this primary measure are the maximal voluntary contraction that will be assessed just before the surgery begins, and the average frequency of muscle activation (mV) over the 2 minute data collection period. Muscle activation for RALS and LS will be compared using this measure.

    Time frame: Intraoperative

Secondary outcomes

  1. Surgeon musculoskeletal health over the last 12 months (Standardized Nordic Questionnaire)

    This questionnaire assesses musculoskeletal symptoms experienced by the surgeons within the last 12 months. It helps to understand the prevalence and location of pain and discomfort before they participate in the study. This questionnaire primarily yields categorical data. For each of the nine body regions (neck, shoulders, upper back, elbows, low back, wrists/hands, hips/thighs, knees, ankles/feet), it asks about trouble (ache, pain, discomfort) in the past 12 months and in the past 7 days. It also asks if the trouble prevented normal work (at home or away from home).

    Time frame: Preoperative

  2. Surgeon physical activity participation status (International Physical Activity Questionnaire

    The frequency, duration, and intensity of different types of physical activities (vigorous, moderate, walking, and sitting) undertaken by the surgeons. It aims to quantify their overall physical activity level. Can be reported as continuous scores (Metabolic Equivalent of Task - minutes per week, or MET-min/week) calculated by multiplying duration, frequency, and standard MET intensity values for each activity type. It can also be categorized into low, moderate, and high physical activity levels based on specific criteria related to frequency, duration, and total MET-min/week.

    Time frame: Preoperative

  3. Surgeon well-being and quality of life (SF36 Health and Wellbeing Questionnaire)

    This assesses the surgeon's health-related quality of life across eight dimensions: Physical Functioning, Role Limitations due to Physical Health Problems, Bodily Pain, General Health Perceptions, Vitality (energy/fatigue), Social Functioning, Role Limitations due to Emotional Problems,1 and Mental Health (emotional well-being). This yields eight scaled scores ranging from 0 to 100, with higher scores indicating better health status in each dimension. Scoring involves recoding items, summing within scales, and then transforming to the standardized range using specific algorithms. Summary scores (PCS and MCS) can also be calculated.

    Time frame: Preoperative

  4. Maximal Voluntary Contraction measured using EMG (mV)

    This will take place with the surgeon producing the a maximal contraction for both their forearm muscles and neck muscles in to create a baseline of comparison to calculate the percentage of maximal contraction that the surgeons experience during surgery.

    Time frame: Intraoperative

  5. Acute muscle activation- percentage of sternocleidomastoid maximal voluntary contraction (%) assesed using EMG frequency.

    This outcome measures the immediate impact of RALS and LS on the surgeon's sternocleidomastoid muscles during a single surgical procedure. It will be quantified by assessing the change in electromyography (EMG) frequency and amplitude recorded during clinically important surgical tasks within the surgeons' first surgery of the day. The contributing measures to this primary measure are the maximal voluntary contraction that will be assessed just before the surgery begins, and the average frequency of muscle activation (mV) over the 2 minute data collection period. Muscle activation for RALS and LS will be compared using this measure.

    Time frame: Intraoperative

  6. Average sternocleidomastoid and forearm muscle EMG amplitude (mV)

    This will be measured using EMG at clinically significant points in the surgery. This will allow for the researchers to assess the muscular demand and the amplitude and frequency of the EMG signal are the direct measures used to quantify this primary variable. Lower amplitude means a greater muscular demand.

    Time frame: Intraoperative

  7. Average sternocleidomastoid and forearm muscle EMG frequency (Hz).

    This will be measured using EMG at clinically significant points in the surgery. This will allow for the researchers to assess the muscular demand and the amplitude and frequency of the EMG signal are the direct measures used to quantify this primary variable. Higher frequency means greater muscular demand.

    Time frame: Intraoperative

  8. Surgeon musculoskeletal health over the last 12 months (Standardized Nordic Questionnaire)

    This questionnaire assesses musculoskeletal symptoms experienced by the surgeons within the last 12 months. It helps to understand the prevalence and location of pain and discomfort before they participate in the study. This questionnaire primarily yields categorical data. For each of the nine body regions (neck, shoulders, upper back, elbows, low back, wrists/hands, hips/thighs, knees, ankles/feet), it asks about trouble (ache, pain, discomfort) in the past 12 months and in the past 7 days. It also asks if the trouble prevented normal work (at home or away from home).

    Time frame: Any time between enrolment in the study and the date of the surgical procedure that the data collection will take place.

07

Study locations

1 site
  • Blackburn Royal Teaching Hospital
    Blackburn, Lancashire, United Kingdom
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided — Only IPD in the published results will potentially be included.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from May 2025 to primary completion in Sep 2025, 4 months.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 23, 2025
First posted
May 18, 2025
StartActual
May 6, 2025
Primary completionActual
Sep 8, 2025
CompletionActual
Sep 8, 2025
Last update
Jan 26, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 26, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06978309
Lead sponsor
Lancaster University
Responsible party
Matthew Davitt (Principal Investigator, Lancaster University) — Principal investigator
First posted
May 18, 2025
Start date
May 6, 2025
Primary completion
Sep 8, 2025
Completion
Sep 8, 2025
Last update
Jan 26, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion